SS
SSII.US SS Innovations International Inc. Common Stock
- Market cap
- USD 267M
- P/E
- -
- P/B
- 5.07x
- ROE
- -32.0%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is SSII.US undervalued?
Graham numberThe Graham number of SS Innovations International Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SS Innovations International Inc. Common Stock fundamental analysis
No fundamental analysis for SS Innovations International Inc. Common Stock yet.
SS Innovations International Inc. Common Stock stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SS Innovations International Inc. Common Stock
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI " Automated Coronary Anastomotic Connector, a micro stapl…
Full company profileSS Innovations International Inc. Common Stock financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SS Innovations International Inc. Common Stock annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | - | 0.00 | 0.00 | 0.00 | 1.46M | 5.88M | 20.6M | 42.5M | 41.8M |
| Gross Profit | - | -789.00 | -19.5K | -37.7K | -37.4K | -37.7K | 490K | 713K | 8.45M | 19.5M | 20.3M |
| Operating Income | -462K | -1.01M | -960K | -3.32M | -1.10M | -3.32M | -5.68M | -20.7M | -19.0M | -8.19M | -16.0M |
| EBITDA | -462K | -1.01M | -941K | -3.33M | -1.09M | -3.33M | -5.34M | -20.3M | -17.7M | -5.98M | -14.4M |
| Net Income | -485K | -1.04M | -960K | -3.39M | -1.12M | -3.39M | -5.60M | -20.9M | -19.2M | -12.1M | -16.0M |
| EPS | -0.25 | -0.53 | -0.46 | -1.57 | -0.48 | -1.57 | -1.41 | -0.16 | -0.11 | -0.06 | -0.08 |
| Balance Sheet | |||||||||||
| Total Assets | 292K | 510K | 145K | 133K | 318K | 133K | 6.98M | 25.5M | 42.4M | 74.2M | 96.5M |
| Total Liabilities | 647K | 409K | 450K | 1.20M | 1.19M | 1.20M | 9.66M | 11.2M | 28.9M | 36.0M | 46.6M |
| Shareholders' Equity | -355K | 101K | -223K | -1.06M | -869K | -1.06M | -2.68M | 14.3M | 13.5M | 38.2M | 49.9M |
| Cash & Short-term Investments | 248K | 453K | 35.7K | 28.5K | 161K | 28.5K | 217K | 7.03M | 467K | 3.21M | 8.11M |
| Total Debt | 480K | - | 30.0K | 458K | 195K | 458K | 8.27M | 8.22M | 18.2M | 14.4M | 19.9M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -190K | -447K | -443K | -424K | -90.5K | -424K | -5.99M | -15.4M | -9.50M | -18.5M | -17.2M |
| Capital Expenditure | 43.5K | 4.17K | 23.6K | 50.1K | 4.00K | 50.1K | 4.56M | 453K | 661K | 3.66M | 2.27M |
| Free Cash Flow | -234K | -451K | -467K | -474K | -94.5K | -474K | -1.44M | -15.8M | -10.2M | -22.2M | -19.5M |
| Ratios | |||||||||||
| ROE | - | -1,026.5% | - | - | - | - | - | -146.5% | -142.3% | -31.7% | -32.0% |
| ROA | -166.0% | -203.5% | -660.3% | -2,555.0% | -353.8% | -2,555.0% | -80.2% | -82.2% | -45.2% | -16.3% | -16.6% |
| Net Profit Margin | - | - | - | - | - | - | -384.1% | -356.2% | -92.7% | -28.5% | -38.3% |
| Debt to Equity | - | - | - | - | - | - | - | 0.57x | 1.35x | 0.38x | 0.40x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
SS Innovations International Inc. Common Stock dividends
SS Innovations International Inc. Common Stock has not paid dividends in the last 9 fiscal years.
Last stock split: 1:10 on Apr 17, 2023.
Who owns SS Innovations International Inc. Common Stock
- Insiders 80.07%
- Institutions 0.87%
- Public & others 19.07%
- Shares outstanding 200M
- Free float 40.7M
Top funds holding SSII.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Hood River International Opp Instl | 833K | 0.42% | 0.00% | Jun 2026 |
| Inspire Small/Mid Cap ETF | 230K | 0.11% | 0.00% | Oct 2026 |
| Handelsbanken Hälsovård (A1 SEK) | 120K | 0.06% | 0.00% | Oct 2026 |
| AlphaCentric Robotics and Automation I | 50.0K | 0.02% | 0.00% | Jun 2026 |
| Fidelity Nasdaq Composite Index | 47.9K | 0.02% | 0.00% | Aug 2026 |
| CIBC US Broad Market Index | 6.28K | 0.00% | 0.00% | Aug 2026 |
| GS Absolute Ret Trkr I Acc EUR Hdg | 1.56K | 0.00% | 0.00% | Aug 2026 |
| Acuitas International Small Cap Instl | 86.00 | 0.00% | -40.69% | Sep 2026 |
Top institutions holding SSII.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Hood River Capital Management LLC | 833K | 0.42% | 0.00% | Jun 2026 |
| CWM Advisors, LLC | 186K | 0.09% | +78.06% | Jun 2026 |
| Handelsbanken Fonder AB | 120K | 0.06% | 0.00% | Jun 2026 |
| Eversept Partners, LP | 110K | 0.05% | 0.00% | Jun 2026 |
| Jnba Financial Advisors Inc | 102K | 0.05% | -12.52% | Jun 2026 |
| UBS Group AG | 51.2K | 0.03% | -67.08% | Jun 2026 |
| AlphaCentric Advisors, LLC | 50.0K | 0.02% | 0.00% | Sep 2026 |
| Geode Capital Management, LLC | 41.8K | 0.02% | +15.15% | Jun 2026 |
| Forum Financial Management, LP | 38.5K | 0.02% | 0.00% | Jun 2026 |
| AlTi Global Inc | 20.6K | 0.01% | 0.00% | Jun 2026 |
| Mariner Wealth Advisors LLC | 19.2K | 0.01% | +2.97% | Jun 2026 |
| IFC & Insurance Marketing, Inc. | 18.3K | 0.01% | -1.88% | Sep 2026 |
| Y-Intercept (Hong Kong) Ltd | 17.9K | 0.01% | 0.00% | Jun 2026 |
| State Street Corp | 14.5K | 0.01% | -6.83% | Jun 2026 |
| PNC Financial Services Group Inc | 13.6K | 0.01% | 0.00% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 3.00K | 0.00% | 0.00% | Jun 2026 |
| Steward Partners Investment Advisory, LLC | 1.10K | 0.00% | 0.00% | Jun 2026 |
| Newbridge Financial Services Group, Inc. | 916.00 | 0.00% | -30.40% | Jun 2026 |
| Mercer Global Advisors Inc. | 850.00 | 0.00% | 0.00% | Jun 2026 |
| JONES FINANCIAL COMPANIES LLLP | 376.00 | 0.00% | 0.00% | Jun 2026 |
SS Innovations International Inc. Common Stock company profile
- Company name
- SS Innovations International Inc. Common Stock
- Ticker
- SSII.US
- Exchange
- USA Stocks
- Listed since
- Oct 17, 2018
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 483
- Fiscal year end
- December
- Address
- 405, iLabs Info Technology Centre, Gurugram, India, 122016
- Phone
- 91 73 3755 3469
- Website
- ssinnovations.com
About SS Innovations International Inc. Common Stock
SS Innovations International, Inc., together with its subsidiaries, operates as a commercial-stage surgical robotics company in India, Philippines, Indonesia, South America, Iraq, Cyprus, Oman, United Arab Emirates (UAE), Nepal, and internationally. It offers SSi Mantra, a surgical robotic system; and SSi Mudra, a range of stapling, energy, and core instrumentations for surgical systems. The company also develops NADI " Automated Coronary Anastomotic Connector, a micro stapling device; SSi Multi-Fire Clip Applier, a cartridge-based clip applicator; SSi Robotic Stapler; SSi Maya is an enabling digital platform that compliments the SSI Mantra system and enhances surgical capabilities; SSi Guru is a virtual tele illustration; SSi XR Cognitive Skill Simulator is an extended reality (XR) software platform developed to train and educate surgeons and surgical assistants; SSi MantraM; SSi Mantra Tele Surgeon Console (TSC); and 5mm surgical instruments; SSi Holographic Anatomy, an augmented reality tool; SSi Chitrasa " Advanced DICOM Viewer, an AI enabled application viewer; and SSi Mixed Reality Headset, a medical-grade device. In addition, it offers instrument tips, including forceps, scissors, electrocautery tools, scalpels, and other surgical tools. Further, the company provides accessory products, such as sterile drapes, 3d stereo endoscopes, cannulas, and seals, as well as tele proctoring and telesurgery products. Additionally, it offers installation, repair, maintenance, 24/7 technical support, and proactive health monitoring services. The company sells its products through direct sales organizations and distributor networks. SS Innovations International, Inc. is headquartered in Gurugram, India.
SS Innovations International Inc. Common Stock management
2- Dr. Sudhir Prem Srivastava M.D.Founder, CEO & Chairman · born 1948
- Mr. Barry F. CohenCOO of Americas & Director · born 1940